BACKGROUND: Frontotemporal lobar degeneration (FTLD) may be inherited as an autosomal dominant disease. Studying patients "at risk" for developing FTLD can provide insights into the earliest onset and evolution of the disease. METHOD: We carried out approximately annual clinical, MRI, and neuropsychological assessments on an asymptomatic 51 year old "at risk" family member from a family with FTLD associated with ubiquitin-positive and tau-negative inclusion bodies. We used non-linear (fluid) registration of serial MRI to determine areas undergoing significant regional atrophy at different stages of the disease. RESULTS: Over the first 26 months of the study, the patient remained asymptomatic, but subsequently developed progressive speech production difficulties, and latterly severe orofacial dyspraxia, dyscalculia, frontal executive impairment, and limb dyspraxia. Regional atrophy was present prior to the onset of symptoms, and was initially centred on the left dorsolateral prefrontal cortex and the left middle frontal gyrus. Latterly, there was increasing asymmetric left frontal and parietal atrophy. Imaging revealed excess and increasing global atrophy throughout the study. Neuropsychological evaluation revealed mild intellectual impairment prior to the onset of these clinical symptoms; frontal executive and left parietal impairment subsequently emerged, culminating in widespread cognitive impairment. Fluid registered MRI allowed the emerging atrophy patterns to be delineated. CONCLUSION: We have demonstrated the onset and progressive pattern of in vivo atrophy in familial FTLD using fluid registered MRI and correlated this with the clinical features. Fluid registered MRI may be a useful technique in assessing patterns of focal atrophy in vivo and demonstrating the progression of degenerative diseases.
BACKGROUND: Frontotemporal lobar degeneration (FTLD) may be inherited as an autosomal dominant disease. Studying patients "at risk" for developing FTLD can provide insights into the earliest onset and evolution of the disease. METHOD: We carried out approximately annual clinical, MRI, and neuropsychological assessments on an asymptomatic 51 year old "at risk" family member from a family with FTLD associated with ubiquitin-positive and tau-negative inclusion bodies. We used non-linear (fluid) registration of serial MRI to determine areas undergoing significant regional atrophy at different stages of the disease. RESULTS: Over the first 26 months of the study, the patient remained asymptomatic, but subsequently developed progressive speech production difficulties, and latterly severe orofacial dyspraxia, dyscalculia, frontal executive impairment, and limb dyspraxia. Regional atrophy was present prior to the onset of symptoms, and was initially centred on the left dorsolateral prefrontal cortex and the left middle frontal gyrus. Latterly, there was increasing asymmetric left frontal and parietal atrophy. Imaging revealed excess and increasing global atrophy throughout the study. Neuropsychological evaluation revealed mild intellectual impairment prior to the onset of these clinical symptoms; frontal executive and left parietal impairment subsequently emerged, culminating in widespread cognitive impairment. Fluid registered MRI allowed the emerging atrophy patterns to be delineated. CONCLUSION: We have demonstrated the onset and progressive pattern of in vivo atrophy in familial FTLD using fluid registered MRI and correlated this with the clinical features. Fluid registered MRI may be a useful technique in assessing patterns of focal atrophy in vivo and demonstrating the progression of degenerative diseases.
Authors: A Ashworth; S Lloyd; J Brown; S Gydesen; S A Sorensen; A Brun; E Englund; C Humphreys; D Housman; M Badura; V Stanton; K Taylor; J Cameron; D Munroe; J Johansson; M Rossor; E M Fisher; J Collinge Journal: Dement Geriatr Cogn Disord Date: 1999 Impact factor: 2.959
Authors: J C Janssen; M Hall; N C Fox; R J Harvey; J Beck; A Dickinson; T Campbell; J Collinge; P L Lantos; L Cipolotti; J M Stevens; M N Rossor Journal: Brain Date: 2000-05 Impact factor: 13.501
Authors: D Neary; J S Snowden; L Gustafson; U Passant; D Stuss; S Black; M Freedman; A Kertesz; P H Robert; M Albert; K Boone; B L Miller; J Cummings; D F Benson Journal: Neurology Date: 1998-12 Impact factor: 9.910
Authors: B A Hosler; T Siddique; P C Sapp; W Sailor; M C Huang; A Hossain; J R Daube; M Nance; C Fan; J Kaplan; W Y Hung; D McKenna-Yasek; J L Haines; M A Pericak-Vance; H R Horvitz; R H Brown Journal: JAMA Date: 2000-10-04 Impact factor: 56.272
Authors: M Hutton; C L Lendon; P Rizzu; M Baker; S Froelich; H Houlden; S Pickering-Brown; S Chakraverty; A Isaacs; A Grover; J Hackett; J Adamson; S Lincoln; D Dickson; P Davies; R C Petersen; M Stevens; E de Graaff; E Wauters; J van Baren; M Hillebrand; M Joosse; J M Kwon; P Nowotny; L K Che; J Norton; J C Morris; L A Reed; J Trojanowski; H Basun; L Lannfelt; M Neystat; S Fahn; F Dark; T Tannenberg; P R Dodd; N Hayward; J B Kwok; P R Schofield; A Andreadis; J Snowden; D Craufurd; D Neary; F Owen; B A Oostra; J Hardy; A Goate; J van Swieten; D Mann; T Lynch; P Heutink Journal: Nature Date: 1998-06-18 Impact factor: 49.962
Authors: Annabel Nelson; Lucy L Russell; Georgia Peakman; Rhian S Convery; Arabella Bouzigues; Caroline V Greaves; Martina Bocchetta; David M Cash; John C van Swieten; Lize Jiskoot; Fermin Moreno; Raquel Sanchez-Valle; Robert Laforce; Caroline Graff; Mario Masellis; Maria Carmela Tartaglia; James B Rowe; Barbara Borroni; Elizabeth Finger; Matthis Synofzik; Daniela Galimberti; Rik Vandenberghe; Alexandre de Mendonça; Chris R Butler; Alexander Gerhard; Simon Ducharme; Isabelle Le Ber; Isabel Santana; Florence Pasquier; Johannes Levin; Markus Otto; Sandro Sorbi; Jonathan D Rohrer Journal: Ann Clin Transl Neurol Date: 2022-03-26 Impact factor: 5.430
Authors: Maya L Henry; Stephen M Wilson; Jennifer M Ogar; Manu S Sidhu; Katherine P Rankin; Tatiana Cattaruzza; Bruce L Miller; Maria Luisa Gorno-Tempini; William W Seeley Journal: Neurocase Date: 2012-11-22 Impact factor: 0.881
Authors: Jonathan D Rohrer; Jennifer M Nicholas; David M Cash; John van Swieten; Elise Dopper; Lize Jiskoot; Rick van Minkelen; Serge A Rombouts; M Jorge Cardoso; Shona Clegg; Miklos Espak; Simon Mead; David L Thomas; Enrico De Vita; Mario Masellis; Sandra E Black; Morris Freedman; Ron Keren; Bradley J MacIntosh; Ekaterina Rogaeva; David Tang-Wai; Maria Carmela Tartaglia; Robert Laforce; Fabrizio Tagliavini; Pietro Tiraboschi; Veronica Redaelli; Sara Prioni; Marina Grisoli; Barbara Borroni; Alessandro Padovani; Daniela Galimberti; Elio Scarpini; Andrea Arighi; Giorgio Fumagalli; James B Rowe; Ian Coyle-Gilchrist; Caroline Graff; Marie Fallström; Vesna Jelic; Anne Kinhult Ståhlbom; Christin Andersson; Håkan Thonberg; Lena Lilius; Giovanni B Frisoni; Michela Pievani; Martina Bocchetta; Luisa Benussi; Roberta Ghidoni; Elizabeth Finger; Sandro Sorbi; Benedetta Nacmias; Gemma Lombardi; Cristina Polito; Jason D Warren; Sebastien Ourselin; Nick C Fox; Martin N Rossor; Giuliano Binetti Journal: Lancet Neurol Date: 2015-02-04 Impact factor: 44.182
Authors: Line Lunau; Kim Mouridsen; Anders Rodell; Leif Ostergaard; Jørgen Erik Nielsen; Adrian Isaacs; Peter Johannsen Journal: BMJ Open Date: 2012-03-15 Impact factor: 2.692
Authors: Jonathan D Rohrer; Jonathan Beck; Vincent Plagnol; Elizabeth Gordon; Tammaryn Lashley; Tamas Revesz; John C Janssen; Nick C Fox; Jason D Warren; Martin N Rossor; Simon Mead; Jonathan M Schott Journal: J Neurol Neurosurg Psychiatry Date: 2013-07-31 Impact factor: 10.154
Authors: Colin J Mahoney; Ivor J A Simpson; Jennifer M Nicholas; Phillip D Fletcher; Laura E Downey; Hannah L Golden; Camilla N Clark; Nicole Schmitz; Jonathan D Rohrer; Jonathan M Schott; Hui Zhang; Sebastian Ourselin; Jason D Warren; Nick C Fox Journal: Ann Neurol Date: 2014-11-17 Impact factor: 10.422
Authors: Jonathan D Rohrer; William D Knight; Jane E Warren; Nick C Fox; Martin N Rossor; Jason D Warren Journal: Brain Date: 2007-10-18 Impact factor: 13.501
Authors: Hannah D Franklin; Lucy L Russell; Georgia Peakman; Caroline V Greaves; Martina Bocchetta; Jennifer Nicholas; Jackie Poos; Rhian S Convery; David M Cash; John van Swieten; Lize Jiskoot; Fermin Moreno; Raquel Sanchez-Valle; Barbara Borroni; Robert Laforce; Mario Masellis; Maria Carmela Tartaglia; Caroline Graff; Daniela Galimberti; James B Rowe; Elizabeth Finger; Matthis Synofzik; Rik Vandenberghe; Alexandre de Mendonça; Fabrizio Tagliavini; Isabel Santana; Simon Ducharme; Chris Butler; Alex Gerhard; Johannes Levin; Adrian Danek; Markus Otto; Sandro Sorbi; Isabelle Le Ber; Florence Pasquier; Jonathan D Rohrer Journal: Alzheimers Res Ther Date: 2021-07-12 Impact factor: 6.982